VR Reduces Pain Anxiety During Arteriovenous Fistula Surgery
ClinicalTrials.gov Studies
Summary
NIH registered a new interventional clinical trial (NCT07538687) investigating virtual reality (VR) as an adjunctive tool for patients undergoing arteriovenous fistula (AVF) surgery. The single-arm study hypothesizes that intraoperative VR immersion will reduce anesthetic doses, decrease patient anxiety and pain, and receive favorable acceptance from surgeons and anesthetists. The trial targets adult patients with end-stage renal disease on dialysis.
What changed
This is a new clinical trial registration on ClinicalTrials.gov, not a regulatory rule or guidance. The study will enroll patients with end-stage renal disease on dialysis undergoing AVF surgery and provide virtual reality immersion as the sole intervention. The primary hypothesis is that VR will lead to reduction in anesthetic doses and decreased patient-reported anxiety and pain.
Healthcare providers and clinical investigators should be aware that VR-based perioperative analgesia is an active area of clinical research. Institutions conducting similar surgical or procedural pain management studies may find this trial relevant for study design benchmarking. No compliance obligations or reporting duties arise from this registration.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
VR Study Virtual Reality for Patients During Arteriovenous Fistula Surgery
N/A NCT07538687 Kind: NA Apr 20, 2026
Abstract
Patients undergoing arterio-venous fistula commonly experience pain and anxiety due to their pre-operative circumstances and the fact that they remain conscious throughout the surgery. It is well documented that perioperative pain and anxiety can cause detrimental effects on patient outcomes and satisfaction. Virtual reality (VR) is increasingly being investigated as an adjunctive tool in various medical and surgical specialties. Current Evidence suggests that VR can be effective in managing both acute and chronic pain, as well as reducing pain, anxiety, stress, and the need for anesthetic agents during surgery. We hypothesize that using VR during AVF surgery will lead to a reduction in anesthetic doses, decreased patient anxiety and pain, and be favorably received by both surgeons and anesthetists.
Conditions: End Stage Renal Disease on Dialysis
Interventions: Virtual Reality
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.